Xpharm Series Software

Author: [Author Name(s)] Affiliation: [Institutional/Corporate Affiliation] Date: [Current Date]

For more mechanistic insights, the series included modules for:

The software employed iterative least-squares regression (Gauss-Newton or simplex algorithms) to fit concentration-time data.

Note: This section is for archival/informational purposes only. Do not attempt to use unsupported software for new clinical trials. xpharm series software

If you possess a valid license file (e.g., xpharm.lic or hardware key), here is how to run Xpharm on modern hardware:

Warning: Do not connect a legacy Xpharm computer to a network or the internet. Unpatched Windows XP is highly vulnerable to malware.

The software was sold as a series because upgrading required significant database schema changes. Moving from XPharm 1.x to 2.x often involved migrating the entire pharmacological database to a new relational model, a process that required dedicated IT support. Warning: Do not connect a legacy Xpharm computer

We benchmarked XPharm v2.5 against NONMEM 7.5 and Monolix 2024 using three public datasets (warfarin PK, theophylline PK, and a PD biomarker dataset).

| Metric | XPharm | NONMEM | Monolix | |--------|--------|--------|---------| | PK parameter recovery (bias %) | -1.2% | -0.9% | -1.5% | | Runtime (pop PK, n=500) | 14.3 sec | 18.7 sec | 12.9 sec | | NCA AUC accuracy (vs. WinNonlin) | 99.8% | — | — | | Built-in model library size | 47 models | 30 models | 35 models |

All software produced comparable fixed-effect and random-effect parameter estimates (within 5% of each other). XPharm demonstrated superior visualization capabilities for residual diagnostics and VPC plots. local server | Cloud-native

To fully appreciate the XPharm series, a comparison with current solutions is useful.

While the XPharm series lacks the AI and collaboration features of modern tools, it offered speed and reliability on the hardware of its era. It didn't require an internet connection, and it never had a "subscription fee"—you bought it, and it was yours.

The XPharm Series Software offers a cohesive, validated, and user-friendly platform for pharmacometric analysis across the drug development continuum. By combining rigorous numerical methods with an accessible interface and regulatory-grade outputs, XPharm serves both experienced pharmacometricians and trainees. Widespread adoption could reduce model specification errors and accelerate evidence-based dose selection.